| Sorafenib resistance in hepatocarcinoma: role of hypoxia-inducible factors C Méndez-Blanco, F Fondevila, A García-Palomo, J González-Gallego, ... Experimental & molecular medicine 50 (10), 1-9, 2018 | 272 | 2018 |
| Melatonin‐induced increase in sensitivity of human hepatocellular carcinoma cells to sorafenib is associated with reactive oxygen species production and mitophagy N Prieto‐Domínguez, R Ordóñez, A Fernández, C Méndez‐Blanco, ... Journal of pineal research 61 (3), 396-407, 2016 | 133 | 2016 |
| Melatonin enhances sorafenib actions in human hepatocarcinoma cells by inhibiting mTORC1/p70S6K/HIF-1α and hypoxia-mediated mitophagy N Prieto-Domínguez, C Méndez-Blanco, S Carbajo-Pescador, ... Oncotarget 8 (53), 91402, 2017 | 84 | 2017 |
| Anti-tumoral activity of single and combined regorafenib treatments in preclinical models of liver and gastrointestinal cancers F Fondevila, C Méndez-Blanco, P Fernández-Palanca, ... Experimental & molecular medicine 51 (9), 1-15, 2019 | 77 | 2019 |
| Antitumor effects of quercetin in hepatocarcinoma in vitro and in vivo models: a systematic review P Fernández-Palanca, F Fondevila, C Méndez-Blanco, MJ Tuñón, ... Nutrients 11 (12), 2875, 2019 | 62 | 2019 |
| Melatonin as an antitumor agent against liver cancer: an updated systematic review P Fernández-Palanca, C Méndez-Blanco, F Fondevila, MJ Tuñón, ... Antioxidants 10 (1), 103, 2021 | 35 | 2021 |
| Stabilization of hypoxia-inducible factors and BNIP3 promoter methylation contribute to acquired sorafenib resistance in human hepatocarcinoma cells C Méndez-Blanco, F Fondevila, P Fernández-Palanca, A García-Palomo, ... Cancers 11 (12), 1984, 2019 | 32 | 2019 |
| Prognostic and clinicopathological significance of hypoxia-inducible factors 1α and 2α in hepatocellular carcinoma: A systematic review with meta-analysis C Méndez-Blanco, P Fernández-Palanca, F Fondevila, ... Therapeutic Advances in Medical Oncology 13, 1758835920987071, 2021 | 22 | 2021 |
| Association of FOXO3 expression with tumor pathogenesis, prognosis and clinicopathological features in hepatocellular carcinoma: a systematic review with meta-analysis F Fondevila, P Fernandez-Palanca, C Mendez-Blanco, T Payo-Serafin, ... Cancers 13 (21), 5349, 2021 | 14 | 2021 |
| Hepatocellular carcinoma cells loss lenvatinib efficacy in vitro through autophagy and hypoxia response-derived neuropilin-1 degradation P Fernández-Palanca, T Payo-Serafín, B San-Miguel, C Méndez-Blanco, ... Acta Pharmacologica Sinica 44 (5), 1066-1082, 2023 | 10 | 2023 |
| Neuropilin-1 as a potential biomarker of prognosis and invasive-related parameters in liver and colorectal cancer: A systematic review and meta-analysis of human studies P Fernández-Palanca, T Payo-Serafín, F Fondevila, C Méndez-Blanco, ... Cancers 14 (14), 3455, 2022 | 9 | 2022 |
| Autophagy-related chemoprotection against sorafenib in human hepatocarcinoma: Role of FOXO3 upregulation and modulation by regorafenib F Fondevila, C Mendez-Blanco, P Fernandez-Palanca, T Payo-Serafin, ... International Journal of Molecular Sciences 22 (21), 11770, 2021 | 8 | 2021 |
| Neuropilins as potential biomarkers in hepatocellular carcinoma: a systematic review of basic and clinical implications P Fernández-Palanca, T Payo-Serafín, C Méndez-Blanco, B San-Miguel, ... Clinical and Molecular Hepatology 29 (2), 293, 2023 | 5 | 2023 |
| Risk versus Benefit of Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials T Payo‐Serafín, C Méndez‐Blanco, P Fernández‐Palanca, ... Clinical Pharmacology & Therapeutics, 2024 | | 2024 |
| Mendez-Blanco et al. Stabilization of Hypoxia-Inducible Factors and BNIP3 Promoter Methylation Contribute to Acquired Sorafenib Resistance in Human Hepatocarcinoma Cells (vol … C Mendez-Blanco, F Fondevila, P Fernandez-Palanca, A Garcia-Palomo, ... Cancers 15 (23), 2023 | | 2023 |
| Correction: Méndez-Blanco et al. Stabilization of Hypoxia-Inducible Factors and BNIP3 Promoter Methylation Contribute to Acquired Sorafenib Resistance in Human Hepatocarcinoma … C Méndez-Blanco, F Fondevila, P Fernández-Palanca, A García-Palomo, ... Cancers 15 (23), 5668, 2023 | | 2023 |
| Relevance of hypoxia-inducible factor 1 alpha in hepatocellular carcinoma: clinical and pre-clinical analysis T Payo-Serafín, P Fernández-Palanca, C Méndez-Blanco, ... Journal of Hepatology 78, S554-S555, 2023 | | 2023 |
| Role of autophagy-mediated neuropilin-1 degradation on lenvatinib efficacy in human hepatocarcinoma P Fernández-Palanca, T Payo-Serafín, F Fondevila, C Méndez-Blanco, ... Journal of Hepatology 77, S639-S640, 2022 | | 2022 |
| Neuropilin-1 as a Potential Biomarker of Prognosis and Invasive-Related Parameters in Liver and Colorectal Cancer: A Systematic Review and Meta-Analysis of Human Studies … P Fernández-Palanca, T Payo-Serafín, F Fondevila, C Méndez-Blanco, ... s Note: MDPI stays neu-tral with regard to jurisdictional claims in …, 2022 | | 2022 |
| HIF-1 alpha ON PROGNOSIS, RECURRENCE AND ACQUISITION OF RESISTANCE TO SORAFENIB IN HEPATOCARCINOMA C Mendez-Blanco, F Fondevila, P Fernandez-Palanca, F Jorquera, ... HEPATOLOGY 74, 300A-300A, 2021 | | 2021 |
Javier González-GallegoProfessor of Physiology. Institute of Biomedicine (IBIOMED), University of León, Spain在 unileon.es 的电子邮件经过验证
